Qube Research & Technologies LTD Biodesix Inc Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Biodesix Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 72,433 shares of BDSX stock, worth $84,022. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,433
Previous 3,068
2260.92%
Holding current value
$84,022
Previous $4,000
3100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BDSX
# of Institutions
57Shares Held
56.2MCall Options Held
2.6KPut Options Held
10.1K-
Telemark Asset Management, LLC Boston, MA8.28MShares$9.61 Million1.58% of portfolio
-
Aigh Capital Management LLC Baltimore, MD5.68MShares$6.59 Million4.09% of portfolio
-
Birchview Capital, LP Burlington, VT5.54MShares$6.43 Million9.1% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.64MShares$5.38 Million0.04% of portfolio
-
Sio Capital Management, LLC New York, NY4.34MShares$5.03 Million4.08% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $46.4M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...